7:00am – 8:00am
Breakfast Symposium
8:20am – 9:00am
Brachytherapy is an Evidence Based Appropriate Treatment Across the Prostate Cancer Disease Spectrum
Faculty:
Mira Keyes, MD, FABS
BC Cancer Agency
8:20am – 9:00am
Candidate Selection and Dosing for Brachytherapy
Faculty:
Monotherapy and Combination Therapy
Joelle Helou, MD, MSc
London Regional Cancer Program
Dose and Constraints for EBRT in Combination with Brachytherapy
Marisa Kollmeier, MD
Memorial Sloan Kettering Cancer Center
Salvage Brachytherapy
Hans Chung, MD
Sunnybrook Odette Cancer Center
9:00am – 9:30am
ADT and Brachytherapy
Faculty:
Recommended Duration of ADT in Combination with Brachytherapy
Dan Krauss, MD
Beaumont Health
Management of ADT Related Toxicities
Laura Hathout, MD
Rutgers Cancer Institute of New Jersey
9:30am – 10:00am
Refreshment Break
10:00am – 10:40am
Procedural Considerations
Faculty:
What Type of Anesthesia is Recommended?
Albert Chang, MD, PhD
UCLA
Essentials of an LDR Implant
Peter Rossi, MD, FABS
Calaway Young Cancer Center at Valley View Hospital
Essentials of an HDR Implant
Juanita Crook, MD, FABS
BC Cancer Agency
10:40am – 11:30am
Organ at Risk Constraints and Management of Toxicities
Faculty:
LDR Constraints
Martin King, MD, PhD
Dana-Farber Brigham and Women's Hospital
HDR Constraints
Gerard Morton, MD, FABS
Sunnybrook Odette Cancer Center
GU Toxicities
Juanita Crook, MD, FABS
BC Cancer Agency
Sexual Toxicities
Michael Folkert, MD, PhD
University of Washington Medical Center
11:30am – 12:00pm
Keynote | Focal Therapy
Faculty:
Daniel Song, MD
Johns Hopkins University
12:00pm – 1:00pm
Lunch Symposium
1:00pm – 4:00pm
Hands-On Learning: HDR
5:00pm – 6:00pm
Welcome Reception
7:00am – 8:00am
Breakfast Symposium
8:00am – 8:40am
Moving Forward
Faculty:
Conidiations for LDR Isotope Selection
Steven Frank, MD, FABS
MD Anderson Cancer Center
Are We Ready to Integrate Genomic Testing into Brachytherapy Management
Peter Orio III, DO, MS, FABS
Dana-Farber Brigham and Women's Hospital
Artificial Intelligence in Prostate Brachytherapy
Martin King, MD, PhD
Dana-Farber Brigham and Women's Hospital
8:40am – 9:20am
The Dominate Intraprostatic Lesion (DIL)
Faculty:
To Boost or Not to Boost the DIL
Daniel Song, MD
Johns Hopkins University
PSMA vs mpMRI for DIL Dilineation
Hans Chung, MD
Sunnybrook Odette Cancer Center
Image Fusion Options for DIL Identification
9:20am – 9:50am
Refreshment Break
9:50am – 10:45am
Brachy ChartRounds (Contouring and Dosimetry Evaluation)
Faculty:
Mitchell Kamrava, MD
Cedars-Sinai Medical Center
Martin King, MD, PhD
Dana-Farber Brigham and Women's Hospital
10:45am – 11:30am
Difficult Cases
Faculty:
Joelle Helou, MD, MSc
London Regional Cancer Program
Marisa Kollmeier, MD
Memorial Sloan Kettering Cancer Center
Albert Chang, MD, PhD
UCLA
11:30am – 12:00pm
Keynote | Lessons Learned in Fractionation
Faculty:
Gerard Morton, MD, FABS
Sunnybrook Odette Cancer Center
12:00pm – 1:00pm
Lunch Symposium
1:00pm – 4:00pm
Hands-On Learning: LDR
7:00am – 8:00am
Breakfast Symposium
8:00am – 8:30am
Brachytherapy Economics and Training
Faculty:
Building a Brachytherapy in Private Practice
Peter Rossi, MD, FABS
Callaway Young Cancer Center at Valley View Hospital
Building a Brachytherapy in Academics
Peter Orio III, DO, MS, FABS
Dana-Farber Brigham and Women's Hospital
8:30am – 9:10am
Spacing
Faculty:
Is there a Role for Spacing in Brachytherapy
Daniel Krauss, MD
Beaumont Health
Timing and Spacing Options
Michael Folkert, MD, PhD
University of Washington Medical Center
Assessment/Management of Complications
Lara Hathout, MD
Rutgers Cancer Institute of New Jersey
9:10am – 9:45am
Refreshment Break
9:45am – 12:00pm
Hands-On Learning
12:00pm
Meeting Adjourns
